Eagle Ralph C, Shields Carol L, Bianciotto Carlos, Jabbour Pascal, Shields Jerry A
Ophthalmic Pathology Laboratory, Wills Eye Institute, Philadelphia, PA 19107, USA.
Arch Ophthalmol. 2011 Nov;129(11):1416-21. doi: 10.1001/archophthalmol.2011.223. Epub 2011 Jul 11.
To describe histopathologic observations in eyes enucleated after intra-arterial chemotherapy (IAC) for retinoblastoma (Rb).
Retrospective histopathologic analysis of 8 eyes.
The eyes were enucleated for tumor viability (n = 4), neovascular glaucoma (n = 2), anaphylactic reaction from IAC (n = 1), and persistent retinal detachment with poor visualization of the tumor (n = 1). Of the 2 eyes judged clinically with complete tumor regression and the 5 with viable tumor, the findings were confirmed on histopathology. The Rb response ranged from minimal (n = 1) to moderate (n = 1) to extensive (n = 4) to complete regression (n = 2). Viable vitreous seeds (n = 4 eyes), invasion into the optic nerve (n = 3), reaching the lamina cribrosa in 2 cases, and invasion into the choroid (n = 1) were observed. Histopathologic evidence of ischemic atrophy involving the outer retina and choroid was found in 4 eyes. One eye treated at another center with IAC and enucleated by our team for recurrence was observed to have extensive choroidal and outer retinal atrophy. This case showed orbital vascular occlusion and subendothelial smooth muscle hyperplasia. Intravascular birefringent foreign material was observed in 5 cases within occluded vessels, stimulating a granulomatous inflammatory response. The foreign material comprised cellulose fibers (n = 3), synthetic fabric fibers (n = 1), or unknown composition (n = 2). Thrombosed blood vessels were identified in 5 eyes and involved ciliary arteries in the retrobulbar orbit (n = 5), scleral emissarial canals (n = 1), small choroidal vessels (n = 1), and central retinal artery (n = 1).
Retinoblastoma can be controlled with IAC, but histopathology of enucleated eyes reveals that ocular complications including thromboembolic events can occur.
描述视网膜母细胞瘤(Rb)动脉内化疗(IAC)后摘除眼球的组织病理学观察结果。
对8只眼球进行回顾性组织病理学分析。
摘除眼球的原因包括肿瘤存活(n = 4)、新生血管性青光眼(n = 2)、IAC过敏反应(n = 1)以及持续性视网膜脱离且肿瘤显示不清(n = 1)。临床判断为肿瘤完全消退的2只眼球以及肿瘤存活的5只眼球,组织病理学结果证实了临床判断。Rb的反应范围从最小(n = 1)到中度(n = 1)、广泛(n = 4)至完全消退(n = 2)。观察到存活的玻璃体种植(n = 4只眼)、视神经侵犯(n = 3),其中2例到达筛板,脉络膜侵犯(n = 1)。4只眼中发现涉及外层视网膜和脉络膜的缺血性萎缩的组织病理学证据。我们团队对1只在另一个中心接受IAC治疗后因复发而摘除的眼球进行观察,发现有广泛的脉络膜和外层视网膜萎缩。该病例显示眼眶血管闭塞和内皮下平滑肌增生。在闭塞血管内观察到5例血管内双折射异物,引发肉芽肿性炎症反应。异物包括纤维素纤维(n = 3)、合成织物纤维(n = 1)或成分不明(n = 2)。5只眼中发现血栓形成的血管,涉及球后眼眶的睫状动脉(n = 5)、巩膜导血管(n = 1)、脉络膜小血管(n = 1)和视网膜中央动脉(n = 1)。
IAC可控制视网膜母细胞瘤,但摘除眼球的组织病理学显示可能发生包括血栓栓塞事件在内的眼部并发症。